Special Sections: Letters to the Editor

Unproven Therapies Don’t Belong in Lyme Disease Guidelines

Authors: Anne Gershon MD, FIDSA

Abstract

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

References1. Ronn SD. In the lymelight: law and clinical practice guidelines. South Med J 2009;102:626–630.RonnSDIn the lymelight: law and clinical practice guidelines.South Med J2009102626-6302. Stricker RB, Johnson JD. The Infectious Diseases Society of America Lyme guidelines: poster child for guideline reform. South Med J 2009;102:565–566.StrickerRB]]JohnsonJDThe Infectious Diseases Society of America Lyme guidelines: poster child for guideline reform.South Med J2009102565-566